dr. randall holcombe discusses regorafenib for metastatic colorectal cancer
Published 11 years ago • 556 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
2:01
dr. holcombe on the progress of colorectal cancer and regorafenib
-
1:08
dr. holcombe discusses aflibercept for mcrc
-
1:36
optimal dosing of regorafenib in colorectal cancer
-
5:53
redos trial: optimizing regorafenib dosing in metastatic colorectal cancer
-
9:34
regorafenib in colorectal cancer
-
3:53
regorafenib in colorectal cancer: optimizing the dose
-
8:14
optimizing treatment with regorafenib in metastic colorectal cancer
-
1:30
dr. nancy l. lewis discusses the correct trial for regorafenib in metastatic colorectal cancer
-
1:10
dr. holcombe on the utility of stool dna test for colon cancer
-
8:47
colorectal cancer: dosing strategies with regorafenib
-
5:25
second-line and salvage treatment of metastatic colorectal cancer
-
3:54
colorectal cancer: patient follow-up with regorafenib
-
6:32
antiangiogenic therapy for metastatic colorectal cancer
-
2:30
second- and third-line therapies in colorectal cancer
-
1:49
dr. george demetri describes the mechanism of action of regorafenib in gist
-
8:26
regorafenib in advanced colorectal cancer: dosing strategies
-
5:32
colorectal cancer: regorafenib patient selection and dosing
-
2:27
dr. bekaii-saab on the redos study in metastatic colorectal cancer
-
0:58
managing colorectal cancer in patients who progress on regorafenib